Literature DB >> 9169759

Evidence of genetic susceptibility to Chlamydia trachomatis-induced pelvic inflammatory disease in the pig-tailed macaque.

A B Lichtenwalner1, D L Patton, Y T Cosgrove Sweeney, L K Gaur, W E Stamm.   

Abstract

The macaque model of chlamydial pelvic inflammatory disease (PID) demonstrates individual variability in the time of onset of intrapelvic adhesions. Some animals develop adhesions rapidly, within 2 weeks after a single tubal inoculation with Chlamydia trachomatis, while in others, adhesions are not observed until 2 weeks after a second tubal inoculation. To test whether this variability correlates with major histocompatibility complex (MHC) class I haplotype, we used macaque alloantisera and mouse anti-HLA monoclonal antibodies to determine the MHC class I haplotypes of 44 C. trachomatis-infected macaques (Macaca nemestrina). Macaques developing gross tubal adhesions after the first chlamydial inoculation were classified as susceptible (n = 29), while those not developing adhesions until after the second chlamydial inoculation were classified as relatively resistant (n = 15), to adhesion formation. Three antibody specificities correlated with susceptibility (odds ratio [OR] 5.2, P < 0.01; OR 6.1 and 4.3, P < 0.05), and two correlated with relative resistance to adhesions (OR 0.1, P < 0.05; OR 0.2, P < 0.01). Because several of these antibodies are cross-reactive, as many as five different MHC class I alleles (three increasing and two decreasing ORs) or as few as two different MHC class I alleles (one increasing and one decreasing OR) could be correlated with risk of adhesion formation. We conclude that in macaques, susceptibility or relative resistance to rapid formation of tubal adhesions is correlated with expression of MHC class I alleles, consistent with reports of MHC class I restriction of chlamydial immunopathology in humans.

Entities:  

Mesh:

Year:  1997        PMID: 9169759      PMCID: PMC175311          DOI: 10.1128/iai.65.6.2250-2253.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  On estimating the relation between blood group and disease.

Authors:  B WOOLF
Journal:  Ann Hum Genet       Date:  1955-06       Impact factor: 1.670

2.  Conservation of the HLA-DQB2 locus in nonhuman primates.

Authors:  L K Gaur; E R Heise; P S Thurtle; G T Nepom
Journal:  J Immunol       Date:  1992-02-01       Impact factor: 5.422

3.  Ancestral major histocompatibility complex DRB genes beget conserved patterns of localized polymorphisms.

Authors:  L K Gaur; G T Nepom
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

Review 4.  Current knowledge on the major histocompatibility complex class II region in non-human primates.

Authors:  B L Slierendregt; R E Bontrop
Journal:  Eur J Immunogenet       Date:  1994-10

5.  The major histocompatibility complex, MnLA, of pigtailed macaques: definition of fifteen specificities.

Authors:  L K Gaur; D M Bowden; C C Tsai; A Davis; E A Clark
Journal:  Hum Immunol       Date:  1989-04       Impact factor: 2.850

6.  Antibody responses to the chlamydial heat shock proteins hsp60 and hsp70 are H-2 linked.

Authors:  G Zhong; R C Brunham
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

7.  The vaginal microflora of pig-tailed macaques and the effects of chlorhexidine and benzalkonium on this ecosystem.

Authors:  D L Patton; Y C Sweeney; L K Rabe; S L Hillier
Journal:  Sex Transm Dis       Date:  1996 Nov-Dec       Impact factor: 2.830

8.  Risk factors for Chlamydia trachomatis pelvic inflammatory disease among sex workers in Nairobi, Kenya.

Authors:  J Kimani; I W Maclean; J J Bwayo; K MacDonald; J Oyugi; G M Maitha; R W Peeling; M Cheang; N J Nagelkerke; F A Plummer; R C Brunham
Journal:  J Infect Dis       Date:  1996-06       Impact factor: 5.226

9.  The major histocompatibility complex (CyLA) of the cynomolgus monkey. I. Serologic definition of 21 specificities.

Authors:  C A Keever; E R Heise
Journal:  Hum Immunol       Date:  1983-07       Impact factor: 2.850

10.  Synovial T lymphocyte-specific immune response to Chlamydia trachomatis in Reiter's disease.

Authors:  J Sieper; G Kingsley; A Palacios-Boix; C Pitzalis; J Treharne; R Hughes; A Keat; G S Panayi
Journal:  Arthritis Rheum       Date:  1991-05
View more
  6 in total

1.  Heat shock protein 60 is the major antigen which stimulates delayed-type hypersensitivity reaction in the macaque model of Chlamydia trachomatis salpingitis.

Authors:  Anne B Lichtenwalner; Dorothy L Patton; Wesley C Van Voorhis; Yvonne T Cosgrove Sweeney; Cho-Chou Kuo
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

2.  Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model.

Authors:  Chunmei Cheng; Sukumar Pal; Ilham Bettahi; Kristie L Oxford; Peter A Barry; Luis M de la Maza
Journal:  Vaccine       Date:  2011-03-04       Impact factor: 3.641

3.  Murine models of Chlamydia trachomatis genital tract infection: use of mouse pneumonitis strain versus human strains.

Authors:  S A Morré; J M Lyons; J I Ito
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

Review 4.  Pathogenesis of Chlamydia induced pelvic inflammatory disease.

Authors:  C R Cohen; R C Brunham
Journal:  Sex Transm Infect       Date:  1999-02       Impact factor: 3.519

5.  Development of a pigtail macaque model of sexually transmitted infection/HIV coinfection using Chlamydia trachomatis, Trichomonas vaginalis, and SHIV(SF162P3).

Authors:  Tara Henning; Yetunde Fakile; Christi Phillips; Elizabeth Sweeney; James Mitchell; Dorothy Patton; Gail Sturdevant; Harlan D Caldwell; W Evan Secor; John Papp; R Michael Hendry; Janet McNicholl; Ellen Kersh
Journal:  J Med Primatol       Date:  2011-08       Impact factor: 0.667

6.  Comparable Genital Tract Infection, Pathology, and Immunity in Rhesus Macaques Inoculated with Wild-Type or Plasmid-Deficient Chlamydia trachomatis Serovar D.

Authors:  Yanyan Qu; Lauren C Frazer; Catherine M O'Connell; Alice F Tarantal; Charles W Andrews; Shelby L O'Connor; Ali N Russell; Jeanne E Sullivan; Taylor B Poston; Abbe N Vallejo; Toni Darville
Journal:  Infect Immun       Date:  2015-07-27       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.